Merck (DE) (Group)

https://www.merck.de

Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 51,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene- editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – Merck is everywhere. In 2017, Merck generated sales of €15.3 billion in 66 countries. Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the “Merck” name and brand. The only exceptions are the United States and Canada, where the business sectors operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. *

	Start	1668-01-01 established_pre
	Industry	pharmaceutical
	Industry 2	reagents (bio/biochemical)
	Person	Garijo, Belén (Merck (DE) 202007– promoted Deputy CEO before CEO of Merck Serono before COO before Sanofi)
	Person 2	von Roeder, Helene (Merck (DE) 202403 CFO)

	Region	Darmstadt
	Country	Germany
	Street	250 Frankfurter Str.
	City	64293 Darmstadt
	Tel	+49-6151-72-0
		Address record changed: 2024-01-05

Basic data	Employees	I: 50,001 to 100,0 (2023-12-31)
	Currency	EUR
	Annual sales	20,993,000,000 (sales, net, consolidated (2023) 2023-12-31)
	Profit	2,834,000,000 (2023-12-31)
	Cash	1,982,000,000 (2023-12-31)

		* Document for »About Section«: Merck KGaA. (3/4/19). "Press Release: Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology". Darmstadt.

		Record changed: 2024-12-29